2013
DOI: 10.1158/1538-7445.am2013-3889
|View full text |Cite
|
Sign up to set email alerts
|

Abstract 3889: GRM1 over-expression in melanoma cells promotes microvesicle formation which functions in stimulating angiogenesis.

Abstract: Our group has reported that metabotropic glutamate receptor 1 (GRM1) as an oncogene and a potential therapeutic target for melanoma. More than 60% of human melanoma expresses GRM1, while normal melanocytes do not. In a Phase-0 trial of riluzole (an oral inhibitor of GRM1) in patients with advanced melanoma we showed suppression of the PI3K/AKT and MAPK pathways in melanoma specimens in 34% of the patients. Our group found that enhanced expression of GRM1 in a subclone of a melanoma cell line (UA… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles